570 related articles for article (PubMed ID: 16413576)
21. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding.
Iyer S; Scotney PD; Nash AD; Ravi Acharya K
J Mol Biol; 2006 May; 359(1):76-85. PubMed ID: 16616187
[TBL] [Abstract][Full Text] [Related]
22. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
23. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
24. Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
Friedman AR; Roberts VA; Tainer JA
Proteins; 1994 Sep; 20(1):15-24. PubMed ID: 7529922
[TBL] [Abstract][Full Text] [Related]
25. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
[TBL] [Abstract][Full Text] [Related]
26. Structure of an anti-DNA fab complexed with a non-DNA ligand provides insights into cross-reactivity and molecular mimicry.
Schuermann JP; Henzl MT; Deutscher SL; Tanner JJ
Proteins; 2004 Nov; 57(2):269-78. PubMed ID: 15340914
[TBL] [Abstract][Full Text] [Related]
27. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
28. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
Scheerer P; Kramer A; Otte L; Seifert M; Wessner H; Scholz C; Krauss N; Schneider-Mergener J; Höhne W
J Mol Recognit; 2007; 20(4):263-74. PubMed ID: 17712773
[TBL] [Abstract][Full Text] [Related]
29. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope.
Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR
J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836
[TBL] [Abstract][Full Text] [Related]
30. Structure of an anti-Lewis X Fab fragment in complex with its Lewis X antigen.
van Roon AM; Pannu NS; de Vrind JP; van der Marel GA; van Boom JH; Hokke CH; Deelder AM; Abrahams JP
Structure; 2004 Jul; 12(7):1227-36. PubMed ID: 15242599
[TBL] [Abstract][Full Text] [Related]
31. Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus.
Bedouelle H; Belkadi L; England P; Guijarro JI; Lisova O; Urvoas A; Delepierre M; Thullier P
FEBS J; 2006 Jan; 273(1):34-46. PubMed ID: 16367746
[TBL] [Abstract][Full Text] [Related]
32. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
33. Interaction of epitope-related and -unrelated peptides with anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab fragment.
Welfle K; Misselwitz R; Höhne W; Welfle H
J Mol Recognit; 2003; 16(1):54-62. PubMed ID: 12557239
[TBL] [Abstract][Full Text] [Related]
34. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
[TBL] [Abstract][Full Text] [Related]
35. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization of an anti-estradiol antibody by site-directed mutagenesis and molecular modelling: modulation of binding properties and prominent role of the V(L) domain in estradiol recognition.
Coulon S; Pellequer JL; Blachère T; Chartier M; Mappus E; Chen Sw SW; Cuilleron CY; Baty D
J Mol Recognit; 2002; 15(1):6-18. PubMed ID: 11870917
[TBL] [Abstract][Full Text] [Related]
37. A mutational analysis of the binding of two different proteins to the same antibody.
Dall'Acqua W; Goldman ER; Eisenstein E; Mariuzza RA
Biochemistry; 1996 Jul; 35(30):9667-76. PubMed ID: 8703938
[TBL] [Abstract][Full Text] [Related]
38. On the nature of antibody combining sites: unusual structural features that may confer on these sites an enhanced capacity for binding ligands.
Padlan EA
Proteins; 1990; 7(2):112-24. PubMed ID: 1691497
[TBL] [Abstract][Full Text] [Related]
39. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response.
Sethi DK; Agarwal A; Manivel V; Rao KV; Salunke DM
Immunity; 2006 Apr; 24(4):429-38. PubMed ID: 16618601
[TBL] [Abstract][Full Text] [Related]
40. Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints.
Scherf T; Hiller R; Naider F; Levitt M; Anglister J
Biochemistry; 1992 Aug; 31(30):6884-97. PubMed ID: 1379072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
